Representations/Ethics and Disclosure/Sanctions Sample Clauses

Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below, and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Iran, Cuba, Sudan, Burma, Syria, or Crimea). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to: ▪ Retractions and withdrawal: Article Withdrawal by ASERS Publishing Only used for Articles in Press which represent early versions of articles and sometimes contain errors, or may have been accidentally submitted twice. Occasionally, but less frequently, the articles may represent infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like. Articles in Press (articles that have been accepted for publication but which have not been formally published and will not yet have the complete volume/issue/page information) that include errors, or are discovered to be accidental duplicates of other published article(s), or are determined to violate our journal publishing ethics guidelines in the view of the editors (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), may be ‘Withdrawn’ from ASERS Publishing. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the ASERS Publishing Policy on Article in Press Withdrawal with a link to the current policy document. Article Withdrawal by ‘Author(s)’ The ‘Author(s)’ could withdrawal the ‘Article’ before acceptation for publication for objective reasons, and the withdrawal must be made written to the Editor in Chief of the Journal. In case that the ‘Author(s)’ withdrawal the ‘Article’ after the acceptation and the payment of publication fee has been performed, ASERS Publishing will not refund the publication fee. The refund of publication fee could be possible only in case in which the ‘Publisher’ will not publish the ‘Article’ for any reasons, except the situation of plagiarism detection after the payment, or dual publication in any language of the same ‘Article’. In such a cases, the ‘Publisher’ will retract the paper from the Journal, webpage ...
AutoNDA by SimpleDocs
Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Russia, Iran, Cuba, North Korea, Democratic Republic of Congo, Sudan, Somalia, Nicaragua, Burma, Syria, Venezuela, Zimbabwe, or Belarus). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to:
Representations/Ethics and Disclosure/Sanctions. I affirm the Author Representations noted below, and confirm that I have reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions. Please note that some journals may require that all co-authors sign and submit Declarations of Interest disclosure forms. I am also aware of the publisher’s policies with respect to retractions and withdrawal (xxxxx://xxx.xxxxxxxx.xxx/about/our-business/policies/article-withdrawal). For further information see the publishing ethics page at xxxxx://xxx.xxxxxxxx.xxx/about/our-business/policies/publishing-ethics and the journal home page. For further information on sanctions, see xxxxx://xxx.xxxxxxxx.xxx/about/our-business/policies/trade-sanctions. Author Representations • The Article I have submitted to the journal for review is original, has been written by the stated authors and has not been previously published. • The Article was not submitted for review to another journal while under review by this journal and will not be submitted to any other journal. • The Article and the Supplemental Materials do not infringe any copyright, violate any other intellectual property, privacy or other rights of any person or entity, or contain any libellous or other unlawful matter. • I have obtained written permission from copyright owners for any excerpts from copyrighted works that are included and have credited the sources in the Article or the Supplemental Materials. • Except as expressly set out in this Journal Publishing Agreement, the Article is not subject to any prior rights or licenses • If I and/or any of my co-authors reside in Iran, Cuba or Syria the Article has been prepared in a personal, academic or research capacity and not as an official representative or otherwise on behalf of the relevant government or institution. • If I am using any personal details or images of patients, research subjects or other individuals, I have obtained all consents required by applicable law and complied with the publisher’s policies relating to the use of such images or personal information. See xxxxx://xxx.xxxxxxxx.xxx/about/our-business/policies/patient-consent for further information. • Any software contained in the Supplemental Materials is free from viruses, contaminants or worms. • If the Article or any of the Supplemental Materials were prepared jointly with other authors, I have informed the co-author...
Representations/Ethics and Disclosure/Sanctions. The ‘Author(s)’ affirms the Author Representations noted below, and confirm that he/she has reviewed and complied with the relevant Instructions to Authors, Ethics in Publishing policy, Declarations of Interest disclosure and information for authors from countries affected by sanctions (Iran, Cuba, Sudan, Burma, Syria, or Crimea). Please note that the ‘Publisher’ may require that all co-authors sign and submit Declarations of Interest disclosure forms. The ‘Author(s)’ is also aware of the publisher’s policies with respect to:

Related to Representations/Ethics and Disclosure/Sanctions

  • Confidentiality and Disclosure of Offering Materials by Potential Investor Potential Investor acknowledges on behalf of itself and any and all Related Parties that the Offering Materials are considered confidential and proprietary information of Owner and/or JLL, and Potential Investor will not make (or cause or permit any Related Party to make) any Offering Materials available, or disclose any of the contents thereof, to any person without Owner’s or JLL’s prior written consent; provided, however, that the Offering Materials may be disclosed to the Potential Investor’s Representative (if any), the Potential Investor's partners, employees, legal counsel, advisors, institutional lenders and other capital sources (collectively the "Related Parties") as reasonably required for an evaluation of the Property. Such Related Parties shall be informed by Potential Investor of the confidential nature of the Offering Materials and the terms of this Agreement and shall be directed by Potential Investor to keep the Offering Materials and related information strictly confidential in accordance with this Agreement and to otherwise abide by the terms of this Agreement as if such party was the Potential Investor hereunder. In the event any Related Party shall take or omit to take any action which if taken or omitted to be taken by Potential Investor would constitute a breach of or a default under the terms hereof, the such act or omission by such Related Party shall be deemed to be a breach of the terms hereof by Potential Investor.

  • Use and Disclosure of PHI Business Associate is limited to the following permitted and required uses or disclosures of PHI:

  • Confidentiality and Disclosure (a) The Agent and each Obligor agree to keep each Funding Rate confidential and not to disclose it to anyone, save to the extent permitted by paragraphs (b) and (c) below.

  • Use and Disclosure of Protected Health Information The Business Associate must not use or further disclose protected health information other than as permitted or required by the Contract or as required by law. The Business Associate must not use or further disclose protected health information in a manner that would violate the requirements of HIPAA Regulations.

  • Uses and Disclosures Pursuant to the terms of this Agreement, Contractor may receive from the Exchange Protected Health Information and/or Personally Identifiable Information in connection with Contractor Exchange Functions that is protected under applicable Federal and State laws and regulations. Contractor shall not use or disclose such Protected Health Information or Personally Identifiable Information obtained in connection with Contractor Exchange Functions other than as is expressly permitted under the Exchange Requirements and only to the extent necessary to perform the functions called for within this Agreement.

  • Representations Warranties and Disclaimers I represent and warrant that I am legally entitled to grant the rights and promises set forth in this Agreement. IN ALL OTHER RESPECTS THE SPECIFICATION IS PROVIDED "AS IS." The entire risk as to implementing or otherwise using the Specification is assumed by the implementer and user. Except as stated herein, I expressly disclaim any warranties (express, implied, or otherwise), including implied warranties of merchantability, non-infringement, fitness for a particular purpose, or title, related to the Specification. IN NO EVENT WILL ANY PARTY BE LIABLE TO ANY OTHER PARTY FOR LOST PROFITS OR ANY FORM OF INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES OF ANY CHARACTER FROM ANY CAUSES OF ACTION OF ANY KIND WITH RESPECT TO THIS AGREEMENT, WHETHER BASED ON BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, AND WHETHER OR NOT THE OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. All of my obligations under Section 3 regarding the transfer, successors in interest, or assignment of Granted Claims will be satisfied if I notify the transferee or assignee of any patent that I know contains Granted Claims of the obligations under Section 3. Nothing in this Agreement requires me to undertake a patent search.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!